An analysis of data on almost 19,000 men found that the use of hair-loss and enlarged prostate drug finasteride was associated with lower risk of developing prostate cancer. The drug, however, had no effect on overall survival rates or survival rates after a prostate cancer diagnosis. The findings appear in the New England Journal of Medicine.

Full Story:
HealthDay News

Related Summaries